Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA:600566)

Market Cap	24.70B -2.9%
Revenue (ttm)	5.90B -17.4%
Net Income	1.74B -18.3%
EPS	1.89 -18.5%
Shares Out	921.66M
PE Ratio	14.18
Forward PE	n/a
Dividend	1.74 (6.63%)
Ex-Dividend Date	Jun 30, 2026

Volume	10,304,661
Open	26.40
Previous Close	26.25
Day's Range	26.01 - 27.00
52-Week Range	21.13 - 29.60
Beta	0.20
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 29, 2026

About SHA:600566

Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of medicines in China. The company offers drugs in the fields of pediatrics, respiratory system, digestive system, and gynecology. It is also involved in daily chemical product sales; and wholesale and retail pharmaceuticals. The company is headquartered in Taixing, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Fei Cao
• Employees: 4,137
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600566

Financial Performance

In 2025, SHA:600566's revenue was 6.22 billion, a decrease of -22.43% compared to the previous year's 8.02 billion. Earnings were 1.78 billion, a decrease of -29.77%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 20, 2026

Data Sources Report a data error